The odds ratio for exposure to L-dopa in the IPD patients with PN was 12.4 (95% confidence interval, 1.4–109.1). There were no differences between the groups in the use of other PD drugs ...

In an era where constant noise and stress have become the norm, maintaining optimal auditory and mental health is more ...

GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

Vesalius Therapeutics, a company pioneering a revolutionary platform to deliver breakthrough treatments for common diseases, ...

L-dopa remains the most powerful antiparkinsonian agent, but a minority of treated patients develop disabling motor response complications. Alternatives to L-dopa for initial treatment of ...

Kebilidi is the first gene therapy approved by the FDA for administration directly into the brain, given via a cannula during ...

In a bid to enhance our understanding of ageing, a team of scientists has uncovered the intricate mechanisms by which ...

Company has Deloitte Haskins & Sells LLP as its auditors. As on 30-09-2024, the company has a total of 137.50 Crore shares outstanding.L&T Share Price Today is Rs. 3547.95 as on 13 Nov, 2024, 03:59 PM ...

This study presents valuable insights into the organization of second-order circuits for gustatory neurons, particularly how they integrate opposing taste inputs and the metabolic states that regulate ...